IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announced its financial results on Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million ($10.8 million) in the second quarter of 2023. The company also reported a 129% year-over-year increase in IMC German sales to CA$3.5 million, making up 24% of the entire company revenue. Oren Shuster, CEO of IMC, said cannabis policy reform in Germany has significantly impacted the company's business. As of this past April, adults over 18 in Germany can legally possess up to 25 grams of dried cannabis and cultivate up to three marijuana plants at home. "We were well positioned to take advantage of the growing market and delivered a 200% increase in sales in Q2,” Shuster said in a press release. “We are actively making sure that we are allotting the resources and support the German business needs to deliver further accelerated growth.” As of this July, adults can also join not-for-profit social clubs where they can buy up to ...